drugset / Trial / NCT00119015

The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis

NCT00119015

RandomizedParallel-groupDouble-blindTreatment

Summary

Some people with nasal allergy symptoms continue to have symptoms even after treatment with a nasal steroid spray. The purpose of this study is to see if these patients are helped by adding another medication (montelukast) to their treatment compared to placebo (a substance that looks like the active medication but does not contain the drug).

Timeline

Start
2005-07
Primary completion
2008-06
Completion
2009-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg Oral
Comparator Fluticasone propionate Other / unclassified 200 ug Intranasal